Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States. uri icon

authors

  • Gower, Emily W
  • Stein, Joshua D
  • Shekhawat, Nakul S
  • Mikkilineni, Shravani
  • Blachley, Taylor S
  • Nick Pajewski, PhD

publication date

  • January 1, 2017